Pregled bibliografske jedinice broj: 106329
Diabetes Mellitus and the Central Nervous System
Diabetes Mellitus and the Central Nervous System // Third Croatian Congress of Pharmacology with International Participation : Abstract Book ; u: Periodicum Biologorum. Supplement / Vitale, Branko ; Lacković, Zdravko (ur.).
Zagreb: Hrvatsko prirodoslovno društvo, 2001. str. 76-76 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 106329 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Diabetes Mellitus and the Central Nervous System
Autori
Šalković-Petrišić, Melita ; Lacković, Zdravko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Third Croatian Congress of Pharmacology with International Participation : Abstract Book ; u: Periodicum Biologorum. Supplement
/ Vitale, Branko ; Lacković, Zdravko - Zagreb : Hrvatsko prirodoslovno društvo, 2001, 76-76
Skup
Croatian Congress of Pharmacology with International Participation (3 ; 2001)
Mjesto i datum
Zagreb, Hrvatska, 18.09.2001. - 21.09.2001
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
diabetes mellitus; brain
Sažetak
Central nervous system has not been usually thought of as a target organ in diabetes mellitus. However, numerous structural, biochemical and behavioral alterations of central nervous system have been demonstrated in diabetes mellitus during the last two decades. The most prominent neurochemical alterations have been observed in neurotransmitter function. In agreement with that, certain mental and neurological, as well as neuroendocrinological disorders related to the neurotransmitter dysfunction appear more often in diabetes mellitus. Monoaminergic alterations in brain, probably most extensively studied so far, have been ascribed to reduced brain uptake of monoamine precursor amino acids. However, regional specificity of monoamine changes, as well as lack of concomitant regional specificity of blood brain barrier permeability for monoamine precursors in diabetes, argue against this hypothesis, supported by introduction of a new experimental model, animals with centrally applied drugs that are selectively toxic for insulin producing/secreting cells. Central, intracerebroventricular application of low, non-diabetogenic doses of these betacytotoxic drugs is accompanied by, in general, similar brain monoamine changes as peripheral administration of high, diabetogenic doses. This may be associated with described brain insulin system, that has regionally distributed insulin content and brain insulin receptors and specific insulin-monoamine interaction, and could be a missing link between monoaminergic alterations of central nervous system and diabetes mellitus. Although not clear yet, the relationship between the central and the peripheral insulin system is likely, as central administration of low betacytotoxic doses does not influence steady-state blood glucose level, but alters glucose tolerance.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti